

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | multicellular organismal water homeostasis (GO:0050891) | 9.40628391 |
| 2 | keratinocyte proliferation (GO:0043616) | 9.16826975 |
| 3 | epidermis development (GO:0008544) | 8.57939817 |
| 4 | molting cycle (GO:0042303) | 8.21348600 |
| 5 | hair cycle (GO:0042633) | 8.21348600 |
| 6 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 7.82245236 |
| 7 | water homeostasis (GO:0030104) | 7.81245536 |
| 8 | lipopolysaccharide metabolic process (GO:0008653) | 6.49354166 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 6.48866107 |
| 10 | desmosome organization (GO:0002934) | 6.10602292 |
| 11 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.08939868 |
| 12 | cellular response to zinc ion (GO:0071294) | 5.98843949 |
| 13 | negative regulation of chondrocyte differentiation (GO:0032331) | 5.88056221 |
| 14 | calcium ion-dependent exocytosis (GO:0017156) | 5.86546487 |
| 15 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 5.84515725 |
| 16 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.83089079 |
| 17 | positive regulation of potassium ion transport (GO:0043268) | 5.69986279 |
| 18 | intermediate filament organization (GO:0045109) | 5.52148426 |
| 19 | detection of bacterium (GO:0016045) | 5.13448773 |
| 20 | intermediate filament cytoskeleton organization (GO:0045104) | 5.03310689 |
| 21 | membrane budding (GO:0006900) | 5.01452017 |
| 22 | regulation of phospholipase A2 activity (GO:0032429) | 4.95680979 |
| 23 | positive regulation of cation channel activity (GO:2001259) | 4.88674406 |
| 24 | intermediate filament-based process (GO:0045103) | 4.87200475 |
| 25 | negative regulation of adenylate cyclase activity (GO:0007194) | 4.84751344 |
| 26 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.83299130 |
| 27 | positive regulation of vesicle fusion (GO:0031340) | 4.82624300 |
| 28 | cellular aldehyde metabolic process (GO:0006081) | 4.82585145 |
| 29 | establishment of viral latency (GO:0019043) | 4.82569344 |
| 30 | keratinocyte development (GO:0003334) | 4.81112318 |
| 31 | linoleic acid metabolic process (GO:0043651) | 4.72492138 |
| 32 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.70789763 |
| 33 | negative regulation of complement activation (GO:0045916) | 4.69739491 |
| 34 | response to phenylpropanoid (GO:0080184) | 4.69256167 |
| 35 | detection of other organism (GO:0098543) | 4.63473767 |
| 36 | negative regulation of cyclase activity (GO:0031280) | 4.59059225 |
| 37 | N-acetylglucosamine metabolic process (GO:0006044) | 4.50866827 |
| 38 | keratinization (GO:0031424) | 4.49787626 |
| 39 | ectoderm development (GO:0007398) | 4.49301217 |
| 40 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.47406716 |
| 41 | regulation of metalloenzyme activity (GO:0048552) | 4.46879819 |
| 42 | glutathione derivative metabolic process (GO:1901685) | 4.42225077 |
| 43 | glutathione derivative biosynthetic process (GO:1901687) | 4.42225077 |
| 44 | negative regulation of lyase activity (GO:0051350) | 4.41956228 |
| 45 | negative regulation of cartilage development (GO:0061037) | 4.39234389 |
| 46 | regulation of potassium ion transmembrane transport (GO:1901379) | 4.38909815 |
| 47 | establishment of integrated proviral latency (GO:0075713) | 4.37676320 |
| 48 | negative regulation of interferon-gamma production (GO:0032689) | 4.32639330 |
| 49 | primary alcohol catabolic process (GO:0034310) | 4.32171483 |
| 50 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.32089812 |
| 51 | uronic acid metabolic process (GO:0006063) | 4.24124289 |
| 52 | glucuronate metabolic process (GO:0019585) | 4.24124289 |
| 53 | fatty acid elongation (GO:0030497) | 4.23746801 |
| 54 | mitochondrial calcium ion transport (GO:0006851) | 4.22853478 |
| 55 | hair cell differentiation (GO:0035315) | 4.21547273 |
| 56 | aldehyde catabolic process (GO:0046185) | 4.20012210 |
| 57 | amino sugar catabolic process (GO:0046348) | 4.19748899 |
| 58 | negative regulation of protein activation cascade (GO:2000258) | 4.18973126 |
| 59 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.07860296 |
| 60 | sequestering of metal ion (GO:0051238) | 4.04062500 |
| 61 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.03868496 |
| 62 | epithelium development (GO:0060429) | 4.00445764 |
| 63 | cellular glucuronidation (GO:0052695) | 3.97608268 |
| 64 | hair follicle morphogenesis (GO:0031069) | 3.97247415 |
| 65 | gap junction assembly (GO:0016264) | 3.96322118 |
| 66 | transepithelial transport (GO:0070633) | 3.96100718 |
| 67 | establishment of skin barrier (GO:0061436) | 3.96010357 |
| 68 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.91319642 |
| 69 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.88475804 |
| 70 | regulation of natural killer cell differentiation (GO:0032823) | 3.86840114 |
| 71 | establishment of planar polarity (GO:0001736) | 3.83690699 |
| 72 | establishment of tissue polarity (GO:0007164) | 3.83690699 |
| 73 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.82724141 |
| 74 | defense response to fungus (GO:0050832) | 3.81687842 |
| 75 | negative regulation of cAMP biosynthetic process (GO:0030818) | 3.81535674 |
| 76 | glucosamine-containing compound metabolic process (GO:1901071) | 3.77260528 |
| 77 | positive regulation of epidermis development (GO:0045684) | 3.77070405 |
| 78 | cholesterol biosynthetic process (GO:0006695) | 3.68631584 |
| 79 | regulation of water loss via skin (GO:0033561) | 3.67521405 |
| 80 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 3.65492074 |
| 81 | negative regulation of cAMP metabolic process (GO:0030815) | 3.62131130 |
| 82 | negative regulation of interleukin-17 production (GO:0032700) | 3.59715264 |
| 83 | epithelial cell differentiation (GO:0030855) | 3.58681421 |
| 84 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.57146513 |
| 85 | mitochondrial calcium ion homeostasis (GO:0051560) | 3.49850286 |
| 86 | negative regulation of cyclic nucleotide metabolic process (GO:0030800) | 3.48017112 |
| 87 | defense response to Gram-negative bacterium (GO:0050829) | 3.44549562 |
| 88 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.43952637 |
| 89 | regulation of neuron projection regeneration (GO:0070570) | 3.42545336 |
| 90 | regulation of axon regeneration (GO:0048679) | 3.42545336 |
| 91 | protein neddylation (GO:0045116) | 3.37127265 |
| 92 | sterol biosynthetic process (GO:0016126) | 3.35309613 |
| 93 | glucosamine-containing compound catabolic process (GO:1901072) | 3.35000054 |
| 94 | negative regulation of acute inflammatory response (GO:0002674) | 3.33910432 |
| 95 | regulation of monocyte chemotaxis (GO:0090025) | 3.32519506 |
| 96 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.29172234 |
| 97 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 3.29121567 |
| 98 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 3.29121567 |
| 99 | negative regulation of lipase activity (GO:0060192) | 3.25918959 |
| 100 | ceramide biosynthetic process (GO:0046513) | 3.22391340 |
| 101 | fibrinolysis (GO:0042730) | 3.21662174 |
| 102 | nitric oxide biosynthetic process (GO:0006809) | 3.17476743 |
| 103 | regulation of keratinocyte differentiation (GO:0045616) | 3.16951031 |
| 104 | eyelid development in camera-type eye (GO:0061029) | 3.16407057 |
| 105 | hypotonic response (GO:0006971) | 3.16195033 |
| 106 | protein homotrimerization (GO:0070207) | 3.14095059 |
| 107 | removal of superoxide radicals (GO:0019430) | 3.12198323 |
| 108 | cellular response to superoxide (GO:0071451) | 3.12198323 |
| 109 | cellular response to oxygen radical (GO:0071450) | 3.12198323 |
| 110 | hydrogen peroxide catabolic process (GO:0042744) | 3.12124353 |
| 111 | regulation of ruffle assembly (GO:1900027) | 3.11448442 |
| 112 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 3.11103172 |
| 113 | surfactant homeostasis (GO:0043129) | 3.10993119 |
| 114 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.05757479 |
| 115 | phosphatidylserine metabolic process (GO:0006658) | 3.01385582 |
| 116 | positive regulation of T cell chemotaxis (GO:0010820) | 3.00286627 |
| 117 | regulation of T cell chemotaxis (GO:0010819) | 3.00286627 |
| 118 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.98159912 |
| 119 | negative regulation of humoral immune response (GO:0002921) | 2.97768189 |
| 120 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.97502992 |
| 121 | antimicrobial humoral response (GO:0019730) | 2.96142640 |
| 122 | negative regulation of catenin import into nucleus (GO:0035414) | 2.94248850 |
| 123 | membrane raft organization (GO:0031579) | 2.92963621 |
| 124 | glutathione metabolic process (GO:0006749) | 2.92626541 |
| 125 | skin morphogenesis (GO:0043589) | 2.89648988 |
| 126 | regulation of epidermis development (GO:0045682) | 2.87559919 |
| 127 | ethanol metabolic process (GO:0006067) | 2.85364503 |
| 128 | glyoxylate metabolic process (GO:0046487) | 2.84229797 |
| 129 | glial cell migration (GO:0008347) | 2.84111910 |
| 130 | leukocyte degranulation (GO:0043299) | 2.82718294 |
| 131 | notochord development (GO:0030903) | 2.80886606 |
| 132 | ethanol oxidation (GO:0006069) | 2.80239028 |
| 133 | neutrophil activation (GO:0042119) | 2.79485804 |
| 134 | DNA deamination (GO:0045006) | 2.79252871 |
| 135 | peptide cross-linking (GO:0018149) | 2.78665961 |
| 136 | apical protein localization (GO:0045176) | 2.78458256 |
| 137 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.77474802 |
| 138 | regulation of interleukin-8 secretion (GO:2000482) | 2.77116910 |
| 139 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.76318338 |
| 140 | lipoxygenase pathway (GO:0019372) | 2.75393657 |
| 141 | regulation of epidermal cell differentiation (GO:0045604) | 2.73995463 |
| 142 | positive regulation of transporter activity (GO:0032411) | 2.72607633 |
| 143 | type B pancreatic cell proliferation (GO:0044342) | 2.71964237 |
| 144 | chemical homeostasis within a tissue (GO:0048875) | 2.71494343 |
| 145 | adhesion of symbiont to host cell (GO:0044650) | 2.70400301 |
| 146 | virion attachment to host cell (GO:0019062) | 2.70400301 |
| 147 | cortical actin cytoskeleton organization (GO:0030866) | 2.67228946 |
| 148 | positive regulation of glomerulus development (GO:0090193) | 2.65123341 |
| 149 | detection of external biotic stimulus (GO:0098581) | 2.65109056 |
| 150 | retinol metabolic process (GO:0042572) | 2.64484459 |
| 151 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.61189913 |
| 152 | interferon-gamma secretion (GO:0072643) | 2.61034010 |
| 153 | N-acetylneuraminate metabolic process (GO:0006054) | 2.59558283 |
| 154 | hemidesmosome assembly (GO:0031581) | 2.57642282 |
| 155 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.57495896 |
| 156 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.56015837 |
| 157 | cullin deneddylation (GO:0010388) | 2.55715111 |
| 158 | response to UV-B (GO:0010224) | 2.55536165 |
| 159 | keratan sulfate catabolic process (GO:0042340) | 2.53796481 |
| 160 | one-carbon compound transport (GO:0019755) | 2.53770894 |
| 161 | regulated secretory pathway (GO:0045055) | 2.53421252 |
| 162 | polyketide metabolic process (GO:0030638) | 2.53343329 |
| 163 | doxorubicin metabolic process (GO:0044598) | 2.53343329 |
| 164 | daunorubicin metabolic process (GO:0044597) | 2.53343329 |
| 165 | polyol transport (GO:0015791) | 2.53113764 |
| 166 | regulation of potassium ion transport (GO:0043266) | 2.53085445 |
| 167 | polarized epithelial cell differentiation (GO:0030859) | 2.50726313 |
| 168 | negative regulation of endopeptidase activity (GO:0010951) | 2.48575122 |
| 169 | molting cycle process (GO:0022404) | 2.48156137 |
| 170 | hair cycle process (GO:0022405) | 2.48156137 |
| 171 | negative regulation of peptidase activity (GO:0010466) | 2.47406197 |
| 172 | response to fungus (GO:0009620) | 2.46864790 |
| 173 | positive regulation of p38MAPK cascade (GO:1900745) | 2.46409506 |
| 174 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.42912871 |
| 175 | epithelial cell-cell adhesion (GO:0090136) | 2.40745673 |
| 176 | regulation of T cell migration (GO:2000404) | 2.38347057 |
| 177 | positive regulation of humoral immune response (GO:0002922) | 2.38180654 |
| 178 | alditol phosphate metabolic process (GO:0052646) | 2.38133986 |
| 179 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.38025177 |
| 180 | positive regulation of cholesterol efflux (GO:0010875) | 2.37816346 |
| 181 | complement activation, classical pathway (GO:0006958) | 2.35490059 |
| 182 | regulation of keratinocyte proliferation (GO:0010837) | 2.34145860 |
| 183 | phospholipid catabolic process (GO:0009395) | 2.31854846 |
| 184 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.30273128 |
| 185 | keratinocyte differentiation (GO:0030216) | 14.9895829 |
| 186 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 13.6616126 |
| 187 | epidermal cell differentiation (GO:0009913) | 12.0413108 |
| 188 | acrosome reaction (GO:0007340) | 10.6452562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 9.65362644 |
| 2 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 6.59435414 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.28313521 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.68158167 |
| 5 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 4.61215557 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.02354482 |
| 7 | TP53_16413492_ChIP-PET_HCT116_Human | 3.05909222 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.79334706 |
| 9 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.70578011 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.64499626 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.58623295 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.41079039 |
| 13 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.40605099 |
| 14 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.40605099 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.39403180 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.26786741 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.25789945 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.09489634 |
| 19 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.06545254 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.02963320 |
| 21 | TP63_22573176_ChIP-Seq_HFKS_Human | 2.01200573 |
| 22 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.00227657 |
| 23 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.95897327 |
| 24 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.95897327 |
| 25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.91518219 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.88699880 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84937203 |
| 28 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.80936029 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.80405547 |
| 30 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.79436077 |
| 31 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.74429669 |
| 32 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.71241211 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66468387 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.66234178 |
| 35 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.63493011 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.62344156 |
| 37 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.60693482 |
| 38 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.58057404 |
| 39 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.57694121 |
| 40 | CJUN_26792858_Chip-Seq_BT549_Human | 1.57178807 |
| 41 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.55167575 |
| 42 | RXR_22108803_ChIP-Seq_LS180_Human | 1.51414496 |
| 43 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.50895281 |
| 44 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.49645774 |
| 45 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.48309908 |
| 46 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.47028666 |
| 47 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.45249509 |
| 48 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.44935102 |
| 49 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.42777149 |
| 50 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.41038356 |
| 51 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.38456162 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32733866 |
| 53 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.31226509 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30142205 |
| 55 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.29270588 |
| 56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27411921 |
| 57 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27408861 |
| 58 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24462644 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23759210 |
| 60 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.22963947 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22957688 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22257661 |
| 63 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21812348 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21586477 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21253101 |
| 66 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21044116 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20321376 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20073623 |
| 69 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.19715841 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19556800 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19077571 |
| 72 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.16639872 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16514577 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16462214 |
| 75 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.15708680 |
| 76 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.14898786 |
| 77 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14418262 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12206100 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12148038 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08419939 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07837438 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07151920 |
| 83 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.06893412 |
| 84 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06069867 |
| 85 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05656227 |
| 86 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05264580 |
| 87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03904500 |
| 88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02954161 |
| 89 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02648723 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02042368 |
| 91 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.99613615 |
| 92 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99311997 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98019684 |
| 94 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96751598 |
| 95 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96315450 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94276665 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93366753 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93283945 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92685539 |
| 100 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92532733 |
| 101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91918026 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91169730 |
| 103 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90742594 |
| 104 | P68_20966046_ChIP-Seq_HELA_Human | 0.88910814 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87804001 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87564914 |
| 107 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.87147597 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86356899 |
| 109 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85321322 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84409327 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82420941 |
| 112 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.80217590 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80145581 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80145581 |
| 115 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.78582724 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78186694 |
| 117 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78096487 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77698071 |
| 119 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76811972 |
| 120 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.76476554 |
| 121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.75998835 |
| 122 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.75696676 |
| 123 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.75572862 |
| 124 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.75091435 |
| 125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75051789 |
| 126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74708559 |
| 127 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74607477 |
| 128 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.74442986 |
| 129 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74262146 |
| 130 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.73749015 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.73312747 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.71808407 |
| 133 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71563353 |
| 134 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.70899775 |
| 135 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.69721553 |
| 136 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.69691954 |
| 137 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.69586107 |
| 138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.69413469 |
| 139 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.69132084 |
| 140 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.68190517 |
| 141 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.67063039 |
| 142 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.66654131 |
| 143 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66560123 |
| 144 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66109184 |
| 145 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.66077096 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66049206 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65757449 |
| 148 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.65504403 |
| 149 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62092625 |
| 150 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.62027884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 6.23619522 |
| 2 | MP0004233_abnormal_muscle_weight | 6.14274612 |
| 3 | MP0001542_abnormal_bone_strength | 5.94604702 |
| 4 | MP0005451_abnormal_body_composition | 4.61615365 |
| 5 | MP0002796_impaired_skin_barrier | 4.40575976 |
| 6 | MP0005275_abnormal_skin_tensile | 4.13527760 |
| 7 | MP0003186_abnormal_redox_activity | 2.91241873 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.78367455 |
| 9 | MP0004043_abnormal_pH_regulation | 2.63295771 |
| 10 | MP0002736_abnormal_nociception_after | 2.41060165 |
| 11 | MP0000383_abnormal_hair_follicle | 2.38727231 |
| 12 | MP0005501_abnormal_skin_physiology | 2.37943314 |
| 13 | MP0002095_abnormal_skin_pigmentation | 2.32125190 |
| 14 | MP0005409_darkened_coat_color | 2.13113922 |
| 15 | MP0002896_abnormal_bone_mineralization | 2.08436681 |
| 16 | MP0000377_abnormal_hair_follicle | 2.05891966 |
| 17 | MP0001216_abnormal_epidermal_layer | 2.03751620 |
| 18 | MP0002168_other_aberrant_phenotype | 1.99558522 |
| 19 | MP0002282_abnormal_trachea_morphology | 1.93476774 |
| 20 | MP0004947_skin_inflammation | 1.85202984 |
| 21 | MP0003941_abnormal_skin_development | 1.83263426 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.78530011 |
| 23 | MP0005377_hearing/vestibular/ear_phenot | 1.69868804 |
| 24 | MP0003878_abnormal_ear_physiology | 1.69868804 |
| 25 | MP0004885_abnormal_endolymph | 1.69088858 |
| 26 | MP0002060_abnormal_skin_morphology | 1.65080624 |
| 27 | MP0000566_synostosis | 1.62512389 |
| 28 | MP0003786_premature_aging | 1.60729875 |
| 29 | MP0003011_delayed_dark_adaptation | 1.60439217 |
| 30 | MP0003279_aneurysm | 1.60314615 |
| 31 | MP0010771_integument_phenotype | 1.57425452 |
| 32 | MP0001188_hyperpigmentation | 1.56949503 |
| 33 | MP0009931_abnormal_skin_appearance | 1.53944679 |
| 34 | MP0001851_eye_inflammation | 1.53255257 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.52403337 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.49654595 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.43477379 |
| 38 | MP0000749_muscle_degeneration | 1.43465707 |
| 39 | MP0000762_abnormal_tongue_morphology | 1.43457250 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.37383021 |
| 41 | MP0002876_abnormal_thyroid_physiology | 1.35799327 |
| 42 | MP0009115_abnormal_fat_cell | 1.33241327 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.30972905 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.26388938 |
| 45 | MP0008004_abnormal_stomach_pH | 1.24960763 |
| 46 | MP0009379_abnormal_foot_pigmentation | 1.23961836 |
| 47 | MP0004782_abnormal_surfactant_physiolog | 1.23932322 |
| 48 | MP0002009_preneoplasia | 1.23592324 |
| 49 | MP0003724_increased_susceptibility_to | 1.23375630 |
| 50 | MP0000427_abnormal_hair_cycle | 1.22873323 |
| 51 | MP0003385_abnormal_body_wall | 1.20082806 |
| 52 | MP0003329_amyloid_beta_deposits | 1.18616501 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.14992454 |
| 54 | MP0000647_abnormal_sebaceous_gland | 1.13482056 |
| 55 | MP0009053_abnormal_anal_canal | 1.11019738 |
| 56 | MP0001970_abnormal_pain_threshold | 1.10390242 |
| 57 | MP0004272_abnormal_basement_membrane | 1.09849664 |
| 58 | MP0000343_altered_response_to | 1.09689254 |
| 59 | MP0003950_abnormal_plasma_membrane | 1.09255546 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.08597855 |
| 61 | MP0005395_other_phenotype | 1.06055888 |
| 62 | MP0000747_muscle_weakness | 1.05083217 |
| 63 | MP0002295_abnormal_pulmonary_circulatio | 1.04862394 |
| 64 | MP0001853_heart_inflammation | 1.04789119 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.03152864 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.02267380 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 1.01782289 |
| 68 | MP0000579_abnormal_nail_morphology | 1.00895927 |
| 69 | MP0002933_joint_inflammation | 1.00777291 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.00581140 |
| 71 | MP0003075_altered_response_to | 0.99368294 |
| 72 | MP0002139_abnormal_hepatobiliary_system | 0.98976034 |
| 73 | MP0005670_abnormal_white_adipose | 0.96131305 |
| 74 | MP0004484_altered_response_of | 0.93986072 |
| 75 | MP0002160_abnormal_reproductive_system | 0.92995175 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.91351584 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 0.88907686 |
| 78 | MP0003566_abnormal_cell_adhesion | 0.88813431 |
| 79 | MP0005360_urolithiasis | 0.87941017 |
| 80 | MP0004381_abnormal_hair_follicle | 0.87691376 |
| 81 | MP0002163_abnormal_gland_morphology | 0.87229445 |
| 82 | MP0001191_abnormal_skin_condition | 0.86041267 |
| 83 | MP0000372_irregular_coat_pigmentation | 0.84805460 |
| 84 | MP0005085_abnormal_gallbladder_physiolo | 0.80916220 |
| 85 | MP0001346_abnormal_lacrimal_gland | 0.80900874 |
| 86 | MP0000367_abnormal_coat/_hair | 0.80213241 |
| 87 | MP0000371_diluted_coat_color | 0.80164405 |
| 88 | MP0004859_abnormal_synaptic_plasticity | 0.79898542 |
| 89 | MP0000751_myopathy | 0.79745111 |
| 90 | MP0009697_abnormal_copulation | 0.78477644 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.78034907 |
| 92 | MP0004134_abnormal_chest_morphology | 0.76450832 |
| 93 | MP0000604_amyloidosis | 0.76428698 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.75995616 |
| 95 | MP0005266_abnormal_metabolism | 0.74567213 |
| 96 | MP0002234_abnormal_pharynx_morphology | 0.73924165 |
| 97 | MP0003795_abnormal_bone_structure | 0.73735786 |
| 98 | MP0010030_abnormal_orbit_morphology | 0.73691511 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.73473333 |
| 100 | MP0005365_abnormal_bile_salt | 0.71020339 |
| 101 | MP0001784_abnormal_fluid_regulation | 0.70782980 |
| 102 | MP0006054_spinal_hemorrhage | 0.70369758 |
| 103 | MP0005197_abnormal_uvea_morphology | 0.69940751 |
| 104 | MP0005248_abnormal_Harderian_gland | 0.69510004 |
| 105 | MP0005083_abnormal_biliary_tract | 0.69143056 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.64742163 |
| 107 | MP0000163_abnormal_cartilage_morphology | 0.64098493 |
| 108 | MP0002177_abnormal_outer_ear | 0.63353842 |
| 109 | MP0005165_increased_susceptibility_to | 0.62755944 |
| 110 | MP0003315_abnormal_perineum_morphology | 0.62322137 |
| 111 | MP0001177_atelectasis | 0.61985917 |
| 112 | MP0005023_abnormal_wound_healing | 0.61802939 |
| 113 | MP0000467_abnormal_esophagus_morphology | 0.60535262 |
| 114 | MP0001849_ear_inflammation | 0.59637809 |
| 115 | MP0005171_absent_coat_pigmentation | 0.58974350 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.57197256 |
| 117 | MP0005075_abnormal_melanosome_morpholog | 0.57034377 |
| 118 | MP0001243_abnormal_dermal_layer | 0.55963512 |
| 119 | MP0001186_pigmentation_phenotype | 0.55791025 |
| 120 | MP0002113_abnormal_skeleton_development | 0.54788311 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.54735633 |
| 122 | MP0005503_abnormal_tendon_morphology | 0.54656727 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.53952401 |
| 124 | MP0005330_cardiomyopathy | 0.53624154 |
| 125 | MP0004883_abnormal_blood_vessel | 0.52766426 |
| 126 | MP0003091_abnormal_cell_migration | 0.52330019 |
| 127 | MP0002233_abnormal_nose_morphology | 0.52090917 |
| 128 | MP0002075_abnormal_coat/hair_pigmentati | 0.51414266 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.51275011 |
| 130 | MP0002254_reproductive_system_inflammat | 0.50905315 |
| 131 | MP0001958_emphysema | 0.50664583 |
| 132 | MP0005379_endocrine/exocrine_gland_phen | 0.49254037 |
| 133 | MP0001340_abnormal_eyelid_morphology | 0.38923016 |
| 134 | MP0000470_abnormal_stomach_morphology | 0.38756655 |
| 135 | MP0003763_abnormal_thymus_physiology | 0.31581038 |
| 136 | MP0008789_abnormal_olfactory_epithelium | 0.30660373 |
| 137 | MP0002111_abnormal_tail_morphology | 0.30090292 |
| 138 | MP0009780_abnormal_chondrocyte_physiolo | 0.29383936 |
| 139 | MP0009333_abnormal_splenocyte_physiolog | 0.27279996 |
| 140 | MP0005193_abnormal_anterior_eye | 0.26829150 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.26785949 |
| 142 | MP0000685_abnormal_immune_system | 0.26622541 |
| 143 | MP0003755_abnormal_palate_morphology | 0.22549920 |
| 144 | MP0001765_abnormal_ion_homeostasis | 0.22489244 |
| 145 | MP0005394_taste/olfaction_phenotype | 0.22095063 |
| 146 | MP0005499_abnormal_olfactory_system | 0.22095063 |
| 147 | MP0002133_abnormal_respiratory_system | 0.21729088 |
| 148 | MP0005388_respiratory_system_phenotype | 0.21729088 |
| 149 | MP0000627_abnormal_mammary_gland | 0.17928628 |
| 150 | MP0008569_lethality_at_weaning | 0.16613077 |
| 151 | MP0005375_adipose_tissue_phenotype | 0.16203263 |
| 152 | MP0002249_abnormal_larynx_morphology | 0.16179468 |
| 153 | MP0005257_abnormal_intraocular_pressure | 0.13172804 |
| 154 | MP0003828_pulmonary_edema | 0.11667573 |
| 155 | MP0000462_abnormal_digestive_system | 0.11164779 |
| 156 | MP0005508_abnormal_skeleton_morphology | 0.10373880 |
| 157 | MP0002006_tumorigenesis | 0.09704982 |
| 158 | MP0002166_altered_tumor_susceptibility | 0.09167302 |
| 159 | MP0004019_abnormal_vitamin_homeostasis | 0.08537614 |
| 160 | MP0001984_abnormal_olfaction | 0.07563756 |
| 161 | MP0002136_abnormal_kidney_physiology | 0.07425060 |
| 162 | MP0001485_abnormal_pinna_reflex | 0.06456411 |
| 163 | MP0001756_abnormal_urination | 0.06372108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Palmoplantar hyperkeratosis (HP:0000972) | 7.77525836 |
| 2 | * Palmar hyperkeratosis (HP:0010765) | 7.35804293 |
| 3 | Alopecia of scalp (HP:0002293) | 6.13380053 |
| 4 | Thick nail (HP:0001805) | 5.89324854 |
| 5 | Corneal erosion (HP:0200020) | 5.29557048 |
| 6 | Abnormality of the axillary hair (HP:0100134) | 4.82650374 |
| 7 | Abnormality of secondary sexual hair (HP:0009888) | 4.82650374 |
| 8 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.39346362 |
| 9 | * Palmoplantar keratoderma (HP:0000982) | 4.21280384 |
| 10 | Follicular hyperkeratosis (HP:0007502) | 4.16564786 |
| 11 | Ectropion (HP:0000656) | 4.07187624 |
| 12 | Hypohidrosis (HP:0000966) | 4.06587705 |
| 13 | Nail dystrophy (HP:0008404) | 3.90832860 |
| 14 | Conjunctival hamartoma (HP:0100780) | 3.86599520 |
| 15 | Lip pit (HP:0100267) | 3.80128493 |
| 16 | Sparse scalp hair (HP:0002209) | 3.65785664 |
| 17 | Malnutrition (HP:0004395) | 3.58329817 |
| 18 | Multiple enchondromatosis (HP:0005701) | 3.53999024 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.49377989 |
| 20 | Abnormal blistering of the skin (HP:0008066) | 3.46560680 |
| 21 | Increased IgE level (HP:0003212) | 3.43128631 |
| 22 | Pustule (HP:0200039) | 3.34255119 |
| 23 | Absent eyelashes (HP:0000561) | 3.29418427 |
| 24 | Abnormal tarsal ossification (HP:0008369) | 3.29057763 |
| 25 | Abnormality of the salivary glands (HP:0010286) | 3.21770183 |
| 26 | Abnormal cartilage morphology (HP:0002763) | 3.15492026 |
| 27 | Protrusio acetabuli (HP:0003179) | 3.15248773 |
| 28 | Frequent falls (HP:0002359) | 3.01039160 |
| 29 | Vertebral compression fractures (HP:0002953) | 3.00630212 |
| 30 | Eczematoid dermatitis (HP:0000976) | 3.00306176 |
| 31 | Beaking of vertebral bodies (HP:0004568) | 2.89496924 |
| 32 | Intrahepatic cholestasis (HP:0001406) | 2.88795505 |
| 33 | Parakeratosis (HP:0001036) | 2.85520921 |
| 34 | Absent hair (HP:0002298) | 2.84630747 |
| 35 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.83941577 |
| 36 | Sparse eyelashes (HP:0000653) | 2.83804660 |
| 37 | Epiphyseal dysplasia (HP:0002656) | 2.82442167 |
| 38 | Brittle hair (HP:0002299) | 2.81206236 |
| 39 | Pruritus (HP:0000989) | 2.80705408 |
| 40 | Autoimmune hemolytic anemia (HP:0001890) | 2.80564838 |
| 41 | Achilles tendon contracture (HP:0001771) | 2.72762197 |
| 42 | Abnormality of the Achilles tendon (HP:0005109) | 2.70918371 |
| 43 | Pheochromocytoma (HP:0002666) | 2.68768072 |
| 44 | Villous atrophy (HP:0011473) | 2.65918644 |
| 45 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.65918644 |
| 46 | Hypergammaglobulinemia (HP:0010702) | 2.64918981 |
| 47 | Premature rupture of membranes (HP:0001788) | 2.55089176 |
| 48 | Onycholysis (HP:0001806) | 2.54685086 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.54342817 |
| 50 | Dehydration (HP:0001944) | 2.53235322 |
| 51 | Furrowed tongue (HP:0000221) | 2.51344639 |
| 52 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.49953658 |
| 53 | Vertebral hypoplasia (HP:0008417) | 2.49953658 |
| 54 | Cupped ribs (HP:0000887) | 2.47358574 |
| 55 | Palpitations (HP:0001962) | 2.47096960 |
| 56 | Hypotrichosis (HP:0001006) | 2.46640792 |
| 57 | Poor head control (HP:0002421) | 2.42919165 |
| 58 | * Erythema (HP:0010783) | 2.42545785 |
| 59 | Ridged nail (HP:0001807) | 2.41878047 |
| 60 | Ankle contracture (HP:0006466) | 2.41799935 |
| 61 | Pili torti (HP:0003777) | 2.38953323 |
| 62 | Spinal rigidity (HP:0003306) | 2.38371101 |
| 63 | Urticaria (HP:0001025) | 2.38073869 |
| 64 | Hoarse voice (HP:0001609) | 2.36641159 |
| 65 | Erythroderma (HP:0001019) | 2.35186011 |
| 66 | Amniotic constriction ring (HP:0009775) | 2.34099382 |
| 67 | Abnormality of placental membranes (HP:0011409) | 2.34099382 |
| 68 | Irregular epiphyses (HP:0010582) | 2.33492026 |
| 69 | Abnormality of nail color (HP:0100643) | 2.32825280 |
| 70 | Neuroendocrine neoplasm (HP:0100634) | 2.32006370 |
| 71 | Spinal muscular atrophy (HP:0007269) | 2.31348974 |
| 72 | Abnormal foot bone ossification (HP:0010675) | 2.30845268 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.29115232 |
| 74 | Foot dorsiflexor weakness (HP:0009027) | 2.29077771 |
| 75 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.26668416 |
| 76 | Cerebral hemorrhage (HP:0001342) | 2.26494438 |
| 77 | Abnormality of the lumbar spine (HP:0100712) | 2.25600915 |
| 78 | Woolly hair (HP:0002224) | 2.25255163 |
| 79 | Slender build (HP:0001533) | 2.24983232 |
| 80 | Blepharitis (HP:0000498) | 2.24755130 |
| 81 | Milia (HP:0001056) | 2.23455412 |
| 82 | Myokymia (HP:0002411) | 2.23405881 |
| 83 | Barrel-shaped chest (HP:0001552) | 2.22964650 |
| 84 | Fragile skin (HP:0001030) | 2.22486589 |
| 85 | Lower limb amyotrophy (HP:0007210) | 2.20906921 |
| 86 | Abnormal hair laboratory examination (HP:0003328) | 2.20696113 |
| 87 | Neoplasm of the adrenal gland (HP:0100631) | 2.19904639 |
| 88 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.18158302 |
| 89 | Scapular winging (HP:0003691) | 2.16188434 |
| 90 | * Fragile nails (HP:0001808) | 2.14393273 |
| 91 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.13466570 |
| 92 | Steatorrhea (HP:0002570) | 2.09725795 |
| 93 | Distal lower limb amyotrophy (HP:0008944) | 2.06635120 |
| 94 | Abnormality of the foot musculature (HP:0001436) | 2.05389725 |
| 95 | Nonimmune hydrops fetalis (HP:0001790) | 2.04992359 |
| 96 | Cavernous hemangioma (HP:0001048) | 2.04340211 |
| 97 | Natal tooth (HP:0000695) | 2.04271931 |
| 98 | Laryngomalacia (HP:0001601) | 2.03628904 |
| 99 | Cervical subluxation (HP:0003308) | 2.00954759 |
| 100 | Oral leukoplakia (HP:0002745) | 10.5735695 |
| 101 | Melanocytic nevus (HP:0000995) | 1.99519882 |
| 102 | Abnormality of carpal bone ossification (HP:0006257) | 1.97843712 |
| 103 | * Hyperhidrosis (HP:0000975) | 1.97762840 |
| 104 | * Plantar hyperkeratosis (HP:0007556) | 1.95957200 |
| 105 | Myelomeningocele (HP:0002475) | 1.95673209 |
| 106 | Platyspondyly (HP:0000926) | 1.94898870 |
| 107 | Skin nodule (HP:0200036) | 1.92194235 |
| 108 | Angiofibromas (HP:0010615) | 1.90511886 |
| 109 | Adenoma sebaceum (HP:0009720) | 1.90511886 |
| 110 | Corneal dystrophy (HP:0001131) | 1.90395646 |
| 111 | Dry skin (HP:0000958) | 1.90351111 |
| 112 | Deep venous thrombosis (HP:0002625) | 1.89806613 |
| 113 | Gangrene (HP:0100758) | 1.89706429 |
| 114 | Increased serum ferritin (HP:0003281) | 1.89330216 |
| 115 | Distal lower limb muscle weakness (HP:0009053) | 1.89206285 |
| 116 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89099110 |
| 117 | Lack of skin elasticity (HP:0100679) | 1.89047607 |
| 118 | Hamartoma of the eye (HP:0010568) | 1.87683275 |
| 119 | Advanced eruption of teeth (HP:0006288) | 1.87371301 |
| 120 | Torticollis (HP:0000473) | 1.86824191 |
| 121 | Ventricular tachycardia (HP:0004756) | 1.86668769 |
| 122 | Neonatal short-limb short stature (HP:0008921) | 1.86050088 |
| 123 | Fat malabsorption (HP:0002630) | 1.85036189 |
| 124 | Back pain (HP:0003418) | 1.84114875 |
| 125 | Hypoplastic labia majora (HP:0000059) | 1.83292907 |
| 126 | Autoamputation (HP:0001218) | 1.83172741 |
| 127 | Multifactorial inheritance (HP:0001426) | 1.82126908 |
| 128 | Coxa vara (HP:0002812) | 1.81202007 |
| 129 | Hyporeflexia of lower limbs (HP:0002600) | 1.81061760 |
| 130 | Atrophic scars (HP:0001075) | 1.80228702 |
| 131 | Myotonia (HP:0002486) | 1.78654028 |
| 132 | Anonychia (HP:0001798) | 1.78548273 |
| 133 | Vitreoretinal degeneration (HP:0000655) | 1.77866035 |
| 134 | Sepsis (HP:0100806) | 1.77256920 |
| 135 | Systemic lupus erythematosus (HP:0002725) | 1.76474658 |
| 136 | Wormian bones (HP:0002645) | 1.76382836 |
| 137 | Popliteal pterygium (HP:0009756) | 1.76303753 |
| 138 | Prolonged partial thromboplastin time (HP:0003645) | 1.74983563 |
| 139 | Type 1 muscle fiber predominance (HP:0003803) | 1.74674582 |
| 140 | Acanthosis nigricans (HP:0000956) | 1.73871249 |
| 141 | Verrucae (HP:0200043) | 1.73170502 |
| 142 | Papilloma (HP:0012740) | 1.73170502 |
| 143 | Abnormality of the anterior horn cell (HP:0006802) | 1.72853478 |
| 144 | Degeneration of anterior horn cells (HP:0002398) | 1.72853478 |
| 145 | Asymmetric growth (HP:0100555) | 1.72680835 |
| 146 | Recurrent corneal erosions (HP:0000495) | 1.72575832 |
| 147 | Neoplasm of head and neck (HP:0012288) | 1.72493340 |
| 148 | Esophageal neoplasm (HP:0100751) | 1.72493340 |
| 149 | Soft skin (HP:0000977) | 1.72192275 |
| 150 | Abnormality of the frontal sinuses (HP:0002687) | 1.72084886 |
| 151 | Muscle fiber splitting (HP:0003555) | 1.71421363 |
| 152 | Neoplasm of the heart (HP:0100544) | 1.71236785 |
| 153 | Abnormality of the labia majora (HP:0012881) | 1.68402398 |
| 154 | Fine hair (HP:0002213) | 1.59658507 |
| 155 | Abnormality of the neuromuscular junction (HP:0003398) | 1.58619097 |
| 156 | Fatigable weakness (HP:0003473) | 1.58619097 |
| 157 | Curly hair (HP:0002212) | 1.56797478 |
| 158 | Abnormality of hair growth rate (HP:0011363) | 1.56036390 |
| 159 | Slow-growing hair (HP:0002217) | 1.56036390 |
| 160 | * Skin ulcer (HP:0200042) | 1.53574364 |
| 161 | Conical tooth (HP:0000698) | 1.52705743 |
| 162 | Carious teeth (HP:0000670) | 1.49783227 |
| 163 | Seborrheic dermatitis (HP:0001051) | 1.48690445 |
| 164 | Abnormality of the fingernails (HP:0001231) | 1.47385863 |
| 165 | Hamartoma (HP:0010566) | 1.41952515 |
| 166 | Nasolacrimal duct obstruction (HP:0000579) | 1.39069377 |
| 167 | Xerostomia (HP:0000217) | 1.37124761 |
| 168 | Selective tooth agenesis (HP:0001592) | 1.36237079 |
| 169 | Keratoconjunctivitis sicca (HP:0001097) | 1.31300670 |
| 170 | Abnormality of permanent molar morphology (HP:0011071) | 1.31147940 |
| 171 | Abnormality of the dental root (HP:0006486) | 1.31147940 |
| 172 | Taurodontia (HP:0000679) | 1.31147940 |
| 173 | Neonatal death (HP:0003811) | 1.27640416 |
| 174 | Split foot (HP:0001839) | 1.25801086 |
| 175 | Oligodontia (HP:0000677) | 1.24982860 |
| 176 | Abnormality of molar (HP:0011077) | 1.23445012 |
| 177 | Abnormality of molar morphology (HP:0011070) | 1.23445012 |
| 178 | Dry hair (HP:0011359) | 1.22910855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 7.09484141 |
| 2 | MST4 | 4.11248466 |
| 3 | BCKDK | 4.07753985 |
| 4 | TAOK1 | 3.74473213 |
| 5 | STK24 | 3.74332678 |
| 6 | TRPM7 | 3.42879152 |
| 7 | ERBB3 | 3.37907014 |
| 8 | TGFBR1 | 3.29058702 |
| 9 | MAP3K3 | 3.24577743 |
| 10 | TESK1 | 3.23130366 |
| 11 | LIMK1 | 3.14866781 |
| 12 | TESK2 | 3.09261659 |
| 13 | PIM2 | 2.87117065 |
| 14 | MAP2K3 | 2.85375152 |
| 15 | MAP3K11 | 2.81756203 |
| 16 | ARAF | 2.68310477 |
| 17 | MAPKAPK3 | 2.60699592 |
| 18 | PBK | 2.53081633 |
| 19 | TAOK2 | 2.45441454 |
| 20 | DAPK2 | 2.32120901 |
| 21 | RIPK1 | 1.95173946 |
| 22 | FGFR3 | 1.92543863 |
| 23 | GRK6 | 1.92234508 |
| 24 | SCYL2 | 1.82236925 |
| 25 | EPHA3 | 1.55604611 |
| 26 | BCR | 1.49674788 |
| 27 | SGK494 | 1.40755200 |
| 28 | SGK223 | 1.40755200 |
| 29 | PIK3CG | 1.40424741 |
| 30 | NME2 | 1.36722148 |
| 31 | FER | 1.34270049 |
| 32 | EPHB2 | 1.26202431 |
| 33 | MAP2K6 | 1.24308742 |
| 34 | MARK2 | 1.15555387 |
| 35 | DYRK1B | 1.14061129 |
| 36 | PRKD2 | 1.10573201 |
| 37 | ABL2 | 1.09722372 |
| 38 | EEF2K | 1.09715798 |
| 39 | IRAK1 | 1.09405286 |
| 40 | LATS2 | 1.09171291 |
| 41 | DDR2 | 1.07751767 |
| 42 | CAMKK2 | 1.06325160 |
| 43 | TGFBR2 | 1.02881918 |
| 44 | PAK4 | 1.02220524 |
| 45 | TTN | 0.97585952 |
| 46 | RPS6KB2 | 0.97265334 |
| 47 | ERN1 | 0.97103257 |
| 48 | ILK | 0.96798663 |
| 49 | MAPK7 | 0.95353692 |
| 50 | DYRK2 | 0.94615777 |
| 51 | MAP3K9 | 0.94591339 |
| 52 | KDR | 0.91576766 |
| 53 | EPHA4 | 0.91398191 |
| 54 | MYLK | 0.90330696 |
| 55 | LATS1 | 0.85550660 |
| 56 | PRPF4B | 0.84266701 |
| 57 | DMPK | 0.82960592 |
| 58 | PAK3 | 0.80993493 |
| 59 | PTK2 | 0.80099093 |
| 60 | NME1 | 0.79996724 |
| 61 | WNK1 | 0.77007097 |
| 62 | IKBKB | 0.74222036 |
| 63 | PRKCI | 0.72276947 |
| 64 | BLK | 0.71097613 |
| 65 | IRAK2 | 0.69204751 |
| 66 | TLK1 | 0.69058899 |
| 67 | CAMKK1 | 0.68871702 |
| 68 | MAP3K12 | 0.68592325 |
| 69 | PTK6 | 0.68449336 |
| 70 | IKBKE | 0.67727826 |
| 71 | EPHB1 | 0.65461532 |
| 72 | LRRK2 | 0.63245283 |
| 73 | MAP3K1 | 0.63194844 |
| 74 | NTRK3 | 0.60952655 |
| 75 | MAP3K7 | 0.60707379 |
| 76 | STK3 | 0.59645824 |
| 77 | PLK2 | 0.59379414 |
| 78 | EIF2AK1 | 0.58097548 |
| 79 | ACVR1B | 0.55230891 |
| 80 | ALK | 0.54789941 |
| 81 | TRIB3 | 0.53281057 |
| 82 | RAF1 | 0.52656634 |
| 83 | MAP2K1 | 0.52044645 |
| 84 | CDK14 | 0.51884367 |
| 85 | BMX | 0.51758447 |
| 86 | NEK6 | 0.51464981 |
| 87 | GSK3A | 0.51372608 |
| 88 | TBK1 | 0.51361806 |
| 89 | MAP3K5 | 0.51219093 |
| 90 | MTOR | 0.47386938 |
| 91 | ROCK2 | 0.47159049 |
| 92 | MAP3K8 | 0.46934649 |
| 93 | CAMK2G | 0.46648544 |
| 94 | JAK3 | 0.46608121 |
| 95 | DAPK1 | 0.46454692 |
| 96 | FGFR4 | 0.46339358 |
| 97 | CDK11A | 0.45869491 |
| 98 | STK38L | 0.45785370 |
| 99 | AURKA | 0.45639997 |
| 100 | CDK6 | 0.45637869 |
| 101 | HCK | 0.45125843 |
| 102 | MET | 0.44842172 |
| 103 | CDK15 | 0.44748397 |
| 104 | IRAK4 | 0.44155266 |
| 105 | FGR | 0.42570067 |
| 106 | PRKCH | 0.42522777 |
| 107 | CDK18 | 0.42265617 |
| 108 | ERBB4 | 0.42059217 |
| 109 | STK10 | 0.41989728 |
| 110 | MAPK15 | 0.41932255 |
| 111 | GRK5 | 0.41851974 |
| 112 | EIF2AK3 | 0.40886714 |
| 113 | BMPR2 | 0.40830164 |
| 114 | MAPK12 | 0.39622617 |
| 115 | PKN1 | 0.39560372 |
| 116 | SMG1 | 0.39452051 |
| 117 | CDK5 | 0.39426309 |
| 118 | PRKAA2 | 0.38925533 |
| 119 | MINK1 | 0.38686930 |
| 120 | PHKG2 | 0.36047275 |
| 121 | PHKG1 | 0.36047275 |
| 122 | MAPKAPK5 | 0.35976534 |
| 123 | ADRBK1 | 0.35828202 |
| 124 | EGFR | 0.35492031 |
| 125 | MST1R | 0.34761570 |
| 126 | SIK1 | 0.34626386 |
| 127 | GRK7 | 0.33984491 |
| 128 | SGK3 | 0.33865003 |
| 129 | CAMK2D | 0.33525723 |
| 130 | MAP3K2 | 0.33470302 |
| 131 | MAPKAPK2 | 0.33432267 |
| 132 | PRKCE | 0.33372945 |
| 133 | MOS | 0.33148192 |
| 134 | MAP3K6 | 0.33075781 |
| 135 | PRKD1 | 0.33031538 |
| 136 | SGK1 | 0.32790457 |
| 137 | GRK1 | 0.31724897 |
| 138 | PRKCA | 0.31236854 |
| 139 | SGK2 | 0.30688192 |
| 140 | NLK | 0.30203122 |
| 141 | FGFR1 | 0.29959122 |
| 142 | ROCK1 | 0.29797978 |
| 143 | PRKCG | 0.28617054 |
| 144 | RPS6KB1 | 0.28242624 |
| 145 | VRK1 | 0.27686683 |
| 146 | NTRK1 | 0.26917847 |
| 147 | ABL1 | 0.26297663 |
| 148 | SRC | 0.26205736 |
| 149 | KSR2 | 0.26193198 |
| 150 | CDC42BPA | 0.26130971 |
| 151 | CAMK2A | 0.25695451 |
| 152 | CAMK2B | 0.25620196 |
| 153 | PDGFRB | 0.25347594 |
| 154 | ICK | 0.24879598 |
| 155 | PAK2 | 0.24748412 |
| 156 | IRAK3 | 0.24226190 |
| 157 | DYRK3 | 0.24005738 |
| 158 | RET | 0.19953695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 6.49433109 |
| 2 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 6.42991074 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 5.21409407 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 4.99472198 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 4.94801985 |
| 6 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 4.91858270 |
| 7 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 4.24976241 |
| 8 | Tyrosine metabolism_Homo sapiens_hsa00350 | 3.68308528 |
| 9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.51367588 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.44336632 |
| 11 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 3.42659548 |
| 12 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.84060998 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.78417620 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.46102743 |
| 15 | GnRH signaling pathway_Homo sapiens_hsa04912 | 2.40328926 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.33542122 |
| 17 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.30658435 |
| 18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 2.00257139 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 1.87719518 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81574975 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.76640764 |
| 22 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.74792809 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.64626881 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.61665837 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.61239677 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.45627367 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.44750248 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44746783 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.42637644 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39568511 |
| 31 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.36803291 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34066091 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.26038905 |
| 34 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.19285118 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18661818 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12275580 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10305737 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.07595818 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04113792 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03452875 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03181592 |
| 42 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.03009970 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02199271 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.01513910 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.00536442 |
| 46 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98194818 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96276432 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.91339529 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87306984 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87204018 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86752700 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83535872 |
| 53 | Ribosome_Homo sapiens_hsa03010 | 0.82458326 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.82011123 |
| 55 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.77773107 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76774703 |
| 57 | Protein export_Homo sapiens_hsa03060 | 0.75569190 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75065500 |
| 59 | Melanogenesis_Homo sapiens_hsa04916 | 0.73502147 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72878647 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.71119213 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70274673 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68963005 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68915410 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.68398490 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67526541 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65619158 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62157248 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.61483118 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59456866 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59005623 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57490069 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55684346 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54618425 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52914073 |
| 76 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52881581 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52804032 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52526527 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.52314724 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.51832195 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51801491 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.51626533 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51090508 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50967327 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50767925 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50415879 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.49881164 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48489738 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.47721896 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47635115 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47249120 |
| 92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46884981 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46088141 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45372918 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44572171 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43552777 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.42790406 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42645824 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42496211 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.42405935 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41906996 |
| 102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41590171 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40990158 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40495369 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40275824 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39707110 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.39669024 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39524856 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39464278 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39424887 |
| 111 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.39075035 |
| 112 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37929772 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37825869 |
| 114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36713173 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36567708 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.36384759 |
| 117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35583063 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33984893 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32660715 |
| 120 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32493812 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31518289 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.30729436 |
| 123 | Tight junction_Homo sapiens_hsa04530 | 0.30255181 |
| 124 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29305608 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.28161168 |
| 126 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.27178351 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27005769 |
| 128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26926753 |
| 129 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26828654 |
| 130 | Shigellosis_Homo sapiens_hsa05131 | 0.25436464 |
| 131 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.25358124 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24984791 |
| 133 | GABAergic synapse_Homo sapiens_hsa04727 | 0.24953056 |
| 134 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.24408668 |
| 135 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.23715995 |
| 136 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.23319195 |
| 137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22864811 |
| 138 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.22310182 |
| 139 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22158892 |
| 140 | Bile secretion_Homo sapiens_hsa04976 | 0.22005003 |
| 141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21969223 |
| 142 | Phagosome_Homo sapiens_hsa04145 | 0.21218756 |
| 143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21202638 |
| 144 | Focal adhesion_Homo sapiens_hsa04510 | 0.20115647 |
| 145 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.19211352 |
| 146 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17995295 |
| 147 | Adherens junction_Homo sapiens_hsa04520 | 0.17974243 |
| 148 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16989033 |
| 149 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.16809591 |
| 150 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.15345416 |
| 151 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.15292909 |
| 152 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.15232634 |
| 153 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.15056240 |
| 154 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.14777432 |
| 155 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.13336897 |
| 156 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.13197555 |
| 157 | Cocaine addiction_Homo sapiens_hsa05030 | 0.12355355 |
| 158 | Salivary secretion_Homo sapiens_hsa04970 | 0.11566592 |
| 159 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.10813342 |
| 160 | Amoebiasis_Homo sapiens_hsa05146 | 0.10098652 |
| 161 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.09596559 |
| 162 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08864552 |
| 163 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.08640823 |
| 164 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.08043443 |
| 165 | Renin secretion_Homo sapiens_hsa04924 | 0.07528348 |

